Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0R0H stock hub

LON/0R0H has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R0His not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

126.8B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R0H

In the news

Latest news · LON/0R0H

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.2

P25 12.9P50 16.9P75 23.5

Trailing P/E24.6

P25 15.9P50 22.9P75 35.8

ROE13.5

P25 -54.2P50 2.1P75 13.7

ROIC9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R0H market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

USD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	125,000
Employees Change	3,000%
Employees Change Percent	2.46
Enterprise value	$156.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US8835561023
Last refreshed	2026-05-10
Market cap	$126.8B
Price	$465
Price currency	USD
Rev Per Employee	272,075.09x
Sector	Healthcare
Sic	3826
Symbol	lon/0R0H
Website	https://www.thermofisher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.06%
EV Earnings	30.31x
EV/EBIT	25.18x
EV/EBITDA	18.1x
EV/FCF	30.76x
EV/Sales	4.71x
FCF yield	4%
Forward P/E	18.21x
P/B ratio	3.24x
P/E ratio	24.61x
P/S ratio	3.73x
PE Ratio10 Y	31.53x
PE Ratio3 Y	31.69x
PE Ratio5 Y	30.99x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.78%
EBITDA Margin	24.99%
FCF margin	14.93%
Gross margin	40.93%
Gross Profit	$13.9B
Gross Profit Growth	4.08%
Gross Profit Growth Q	4.66%
Gross Profit Growth3 Y	1.51%
Gross Profit Growth5 Y	0.02%
Net Income	$5.2B
Net Income Growth	5.13%
Net Income Growth Q	9.56%
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Net Income Growth3 Y	4.37%
Net Income Growth5 Y	-2.88%
Pretax Margin	16.35%
Profit Margin	15.15%
Profit Per Employee	$41,223
Profitable Years	14
ROA	5
Roa5y	5.62
ROCE	8.6
ROE	13.52
Roe5y	15.21
ROIC	8.95
Roic5y	10.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	14.37%
Cagr3y	-4.92%
Cagr5y	0.01%
Div CAGR10	13.56%
Div CAGR3	8.01%
Div CAGR5	13.37%
EPS Growth	6.67
EPS Growth Q	11.31
EPS Growth Quarters	6
EPS Growth Years	2
EPS Growth3 Y	5.84
EPS Growth5 Y	-1.75
FCF Growth	0.36%
FCF Growth Q	126.04%
FCF Growth3 Y	6.29%
FCF Growth5 Y	-3.5%
OCF Growth	1.82%
OCF Growth Q	64.87%
OCF Growth10 Y	10.43%
OCF Growth3 Y	2.56%
OCF Growth5 Y	-3.52%
Revenue Growth	5.36x
Revenue Growth Q	6.19x
Revenue Growth Quarters	7x
Revenue Growth Years	2x
Revenue Growth3 Y	1.05x
Revenue Growth5 Y	4.72x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.43
Assets	$85.2B
Cash	$2.5B
Current Assets	$16.4B
Current Liabilities	$10.7B
Debt	$32.5B
Debt EBITDA	$3.66
Debt Equity	$0.83
Debt FCF	$6.4
Equity	$39.2B
Interest Coverage	5.77
Liabilities	$46.1B
Long Term Assets	$68.9B
Long Term Liabilities	$35.3B
Net Cash	$-30B
Net Cash By Market Cap	$-23.68
Net Debt EBITDA	$3.53
Net Debt Equity	$0.77
Net Debt FCF	$5.91
Tangible Book Value	$-16.9B
Tangible Book Value Per Share	$-45.35
WACC	7.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.53
Inventory Turnover	4.98
Net Working Capital	$5.7B
Quick ratio	0.97
Working Capital	$5.8B
Working Capital Turnover	$3.8

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.38%
Dividend Growth	5.04%
Dividend Growth Years	9%
Dividend per share	$1.31
Dividend Years	9
Dividend Yield	0.28%
Ex Div Date	2026-03-13
Last Dividend	$0.36
Payout Frequency	Quarterly
Payout Ratio	9.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	14.36%
200-day SMA	527
3Y total return	-14.05%
50-day SMA	491.2
50-day SMA vs 200-day SMA	50under200
5Y total return	0.06%
All Time High	671.8
All Time High Change	-30.82%
All Time High Date	2021-12-31
All Time Low	200.2
All Time Low Change	132.15%
All Time Low Date	2018-02-12
ATR	21.33
Beta	0.88
Ch YTD	-20.26
High	483.5
High52	643.5
High52 Date	2026-01-22
High52ch	-27.78%
Low	456.8
Low52	385.9
Low52 Date	2025-06-18
Low52ch	20.43%
Ma50ch	-5.39%
Price vs 200-day SMA	-11.81%
RSI	41.05
RSI Monthly	43.34
RSI Weekly	39.49
Sharpe ratio	0.35x
Sortino ratio	0.73
Total Return	1.66%
Tr YTD	-20.18
Tr1m	-4.5%
Tr1w	-1.28%
Tr3m	-14.42%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$6.4B
Operating Income Growth	8.22
Operating Income Growth Q	7.01
Operating Income Growth3 Y	4.42
Operating Income Growth5 Y	-3.25
Operating margin	18.78

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	370,687,718%
Net Borrowing	5,545,365,840
Shares Insiders	0.13%
Shares Institutions	93.63%
Shares Qo Q	-1.06%
Shares Yo Y	-1.38%
Short Ratio	2.1

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$4.8B
Average Volume	2,840.6x
Bv Per Share	105.2
CAPEX	$-1.2B
Ch1m	-4.5
Ch1w	-1.28
Ch1y	13.94
Ch3m	-14.51
Ch3y	-14.84
Ch5y	-1.28
Ch6m	-18.31
Change	-1.72%
Change From Open	-2.14
Close	472.9
Days Gap	0.43
Depreciation Amortization	2,060,440,826
Dollar Volume	645,031.4
Earnings Date	2026-04-23
EBIT	$6.4B
EBITDA	$8.5B
EPS	$13.69
F Score	4
FCF	$5.1B
FCF EV Yield	3.25x
Financing CF	2,254,400,120
Fiscal Year End	December
Founded	1,956
Goodwill	40,480,437,118
Graham Number	246.96495
Graham Upside	-46.86
Income Tax	$392.8M
Investing CF	-9,391,578,070
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-28
Lynch Fair Value	$94.41
Lynch Upside	-79.68
Ma150	543.3
Ma150ch	-14.46%
Ma20	490.2
Ma20ch	-5.19%
Net CF	-671,203,240
Open	474.9
P FCF Ratio	24.98
P OCF Ratio	20.34
Payment Date	2026-04-15
Position In Range	29.64
Ppne	7,817,792,212
Price Date	2026-05-08
Price EBITDA	$14.92
Relative Volume	0.49x
Revenue	34,009,386,590x
SBC By Revenue	0.7x
Share Based Comp	239,285,460
Tax By Revenue	1.15x
Tax Rate	7.07%
Tr6m	-18.17%
Volume	1,388
Z Score	3.31

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0R0H dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.3%

$1.31 annual per share

Payout ratio

+9.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+13.4%

9 consecutive years of growth

Total shareholder yield

+1.7%

Next ex-dividend date: 2026-03-13

Performance

LON/0R0H stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R0H?

Insider, institutional, and short-interest positioning.

Institutional ownership

+93.6%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0R0H momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.0

Neutral momentum band

Price vs 200-day MA

-11.8%

50/200-day relationship not available

Beta (5Y)

0.88

Moves roughly with the market

Sharpe ratio

0.35

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R0H

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R0H stock rating?

lon/0R0H is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R0H analysis?

The full report lives at /stocks/lon/0R0H/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R0H?

The latest report frames lon/0R0H around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R0H page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.